Clinical Trial Update: Talotrexin in Treating Young Patients With Recurrent Solid Tumors or Leukemia That is Recurrent or Does Not Respond to Treatment [Phase 1]

View source ↗

Summary

Phase 1 trial of talotrexin in children with recurrent solid tumors or leukemia was withdrawn before completion, with cases including brain/CNS tumors, leukemia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Tumor
• Childhood Solid Tumor
• Leukemia
• Lymphoma

Drugs mentioned

• Talotrexin (talotrexin)

Snippet

Sponsor: Children's Oncology Group | Conditions: Brain and Central Nervous System Tumors, Leukemia | Phase 1 | Status: WITHDRAWN